Cargando…
A question–answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study
OBJECTIVE: To assess a question–answer pair (QAP) database integrated with websites developed for drug information centres to answer complex questions effectively. DESIGN: Descriptive study with comparison of two subsequent 6-year periods (1995–2000 and 2001–2006). SETTING: The Regional Medicines In...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307033/ https://www.ncbi.nlm.nih.gov/pubmed/22422916 http://dx.doi.org/10.1136/bmjopen-2011-000642 |
_version_ | 1782227279018983424 |
---|---|
author | Schjøtt, Jan Reppe, Linda A Roland, Pål-Didrik H Westergren, Tone |
author_facet | Schjøtt, Jan Reppe, Linda A Roland, Pål-Didrik H Westergren, Tone |
author_sort | Schjøtt, Jan |
collection | PubMed |
description | OBJECTIVE: To assess a question–answer pair (QAP) database integrated with websites developed for drug information centres to answer complex questions effectively. DESIGN: Descriptive study with comparison of two subsequent 6-year periods (1995–2000 and 2001–2006). SETTING: The Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS). PARTICIPANTS: A randomised sample of QAPs from the RELIS database. PRIMARY OUTCOME MEASURE: Answer time in days compared with Mann–Whitney U test. SECONDARY OUTCOME MEASURE: Number of drugs involved (one, two, three or more), complexity (judgemental and/or patient-related or not) and literature search (none, simple or advanced) compared with χ(2) tests. RESULTS: 842 QAPs (312 from 1995 to 2000 and 530 from 2001 to 2006) were compared. The fraction of judgemental and patient-related questions increased (66%–75% and 54%–72%, respectively, p<0.01). Number of drugs and literature search (>50% advanced) was similar in the two periods, but the fraction of answers referring to the RELIS database increased (13%–31%, p<0.01). Median answer time was reduced from 2 days to 1 (p<0.01), although the fraction of complex questions increased from the first to the second period. Furthermore, the mean number of questions per employee per year increased from 66 to 89 from the first to the second period. CONCLUSIONS: The authors conclude that RELIS has a potential to efficiently answer complex questions. The model is of relevance for organisation of drug information centres. |
format | Online Article Text |
id | pubmed-3307033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BMJ Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-33070332012-03-21 A question–answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study Schjøtt, Jan Reppe, Linda A Roland, Pål-Didrik H Westergren, Tone BMJ Open Pharmacology and Therapeutics OBJECTIVE: To assess a question–answer pair (QAP) database integrated with websites developed for drug information centres to answer complex questions effectively. DESIGN: Descriptive study with comparison of two subsequent 6-year periods (1995–2000 and 2001–2006). SETTING: The Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS). PARTICIPANTS: A randomised sample of QAPs from the RELIS database. PRIMARY OUTCOME MEASURE: Answer time in days compared with Mann–Whitney U test. SECONDARY OUTCOME MEASURE: Number of drugs involved (one, two, three or more), complexity (judgemental and/or patient-related or not) and literature search (none, simple or advanced) compared with χ(2) tests. RESULTS: 842 QAPs (312 from 1995 to 2000 and 530 from 2001 to 2006) were compared. The fraction of judgemental and patient-related questions increased (66%–75% and 54%–72%, respectively, p<0.01). Number of drugs and literature search (>50% advanced) was similar in the two periods, but the fraction of answers referring to the RELIS database increased (13%–31%, p<0.01). Median answer time was reduced from 2 days to 1 (p<0.01), although the fraction of complex questions increased from the first to the second period. Furthermore, the mean number of questions per employee per year increased from 66 to 89 from the first to the second period. CONCLUSIONS: The authors conclude that RELIS has a potential to efficiently answer complex questions. The model is of relevance for organisation of drug information centres. BMJ Group 2012-03-15 /pmc/articles/PMC3307033/ /pubmed/22422916 http://dx.doi.org/10.1136/bmjopen-2011-000642 Text en © 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode. |
spellingShingle | Pharmacology and Therapeutics Schjøtt, Jan Reppe, Linda A Roland, Pål-Didrik H Westergren, Tone A question–answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study |
title | A question–answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study |
title_full | A question–answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study |
title_fullStr | A question–answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study |
title_full_unstemmed | A question–answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study |
title_short | A question–answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study |
title_sort | question–answer pair (qap) database integrated with websites to answer complex questions submitted to the regional medicines information and pharmacovigilance centres in norway (relis): a descriptive study |
topic | Pharmacology and Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307033/ https://www.ncbi.nlm.nih.gov/pubmed/22422916 http://dx.doi.org/10.1136/bmjopen-2011-000642 |
work_keys_str_mv | AT schjøttjan aquestionanswerpairqapdatabaseintegratedwithwebsitestoanswercomplexquestionssubmittedtotheregionalmedicinesinformationandpharmacovigilancecentresinnorwayrelisadescriptivestudy AT reppelindaa aquestionanswerpairqapdatabaseintegratedwithwebsitestoanswercomplexquestionssubmittedtotheregionalmedicinesinformationandpharmacovigilancecentresinnorwayrelisadescriptivestudy AT rolandpaldidrikh aquestionanswerpairqapdatabaseintegratedwithwebsitestoanswercomplexquestionssubmittedtotheregionalmedicinesinformationandpharmacovigilancecentresinnorwayrelisadescriptivestudy AT westergrentone aquestionanswerpairqapdatabaseintegratedwithwebsitestoanswercomplexquestionssubmittedtotheregionalmedicinesinformationandpharmacovigilancecentresinnorwayrelisadescriptivestudy AT schjøttjan questionanswerpairqapdatabaseintegratedwithwebsitestoanswercomplexquestionssubmittedtotheregionalmedicinesinformationandpharmacovigilancecentresinnorwayrelisadescriptivestudy AT reppelindaa questionanswerpairqapdatabaseintegratedwithwebsitestoanswercomplexquestionssubmittedtotheregionalmedicinesinformationandpharmacovigilancecentresinnorwayrelisadescriptivestudy AT rolandpaldidrikh questionanswerpairqapdatabaseintegratedwithwebsitestoanswercomplexquestionssubmittedtotheregionalmedicinesinformationandpharmacovigilancecentresinnorwayrelisadescriptivestudy AT westergrentone questionanswerpairqapdatabaseintegratedwithwebsitestoanswercomplexquestionssubmittedtotheregionalmedicinesinformationandpharmacovigilancecentresinnorwayrelisadescriptivestudy |